Eye Disease and the Older Diabetic

Clinics in Geriatric Medicine

Volumn 24, Issue 3, 2008, Pages 515-527

  Tumosa, Nina ^a,b  

^a Education   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C INHIBITOR; STEROID; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN INHIBITOR;

ATTENUATION; BLINDNESS; BLOOD GLUCOSE MONITORING; CATARACT; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; DRY EYE; EARLY DIAGNOSIS; EXERCISE; EYE DISEASE; EYE EXAMINATION; GERIATRIC PATIENT; GLAUCOMA; HUMAN; LASER COAGULATION; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); NUTRITION; RETINA DETACHMENT; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT INDICATION; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

AGED; DIABETES COMPLICATIONS; EYE DISEASES; HUMANS; RISK FACTORS; VISION DISORDERS;

EID: 48049089408     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2008.03.002     Document Type: Review

References (94)

1. National Institutes of Health. Available at:. www.nei.nih.gov/eyedatap Accessed December 23, 2007
2. World Health Organization. Available at:. http://www.who.int/mediacentre/factsheets/fs282/en/accessed Accessed December 25, 2007
3. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 5 (2004) 1047-1053
4. Sinclair A.J., Bayer A.J., Girling A.J., et al. Older adults, diabetes mellitus and visual acuity: a community-based case-control study. Age Ageing 29 (2000) 335-339
5. Idil A., Caliskan D., and Ocaktan E. The prevalence of blindness and low vision in older onset diabetes mellitus and associated factors: a community-based study. Eur J Ophthalmol 14 (2004) 298-305
6. Cikamatana L., Mitchell P., Rochtchina E., et al. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye 21 4 (2007) 465-471
7. Roy M.S. Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment. Arch Ophthalmol 118 1 (2000) 97-104
8. Harris M.I., Hadden W.C., Knowler W.C., et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36 4 (1987) 523-534
9. Roy M.S., and Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 124 9 (2006) 1297-1306
10. Varma R., Torres M., Pena F., et al., Los Angeles Latino eye study. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology 111 7 (2004) 1298-1306
11. Bloomgarden Z.T. Screening for and managing diabetic retinopathy: current approaches. Am J Health Syst Pharm 64 12 Suppl 12 (2007) S8-S14
12. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type I diabetes. Ophthalmology 105 10 (1998) 1801-1815
13. Anderson D., Horton C., and O'Toole M. Integrating depression care with diabetes care in real-world settings: lessons from the Robert Wood Johnson Foundation Diabetes Initiative. Diabetes Spectrum 20 (2007) 10-16
14. Roy M.S., Peng B., and Roy A. Risk factors for coronary disease and stroke in previously hospitalized African-Americans with type 1 diabetes: a 6-year follow-up. Diabet Med 24 12 (2007) 1361-1368
15. Juutilainen A., Lehto S., Ronnemaa T., et al. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 30 2 (2007) 292-299
16. Lovestam-Adrian M., Hansson-Lundblad C., and Torffvit O. Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: a 10-year observation study. Diabetes Res Clin Pract 77 1 (2007) 141-147
17. Suto C., Hori S., Kato S., et al. Effect of perioperative glycemic control in progression of diabetic retinopathy and maculopathy. Arch Ophthalmol 124 1 (2006) 38-45
18. Rodin G., Olmsted M.P., Rydall A.C., et al. Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res 53 4 (2002) 943-949
19. Mitchell P., Smith W., Wang J.J., et al. Prevalence of diabetic retinopathy in an older community. The Blue Mountain Study. Ophthalmology 105 3 (1998) 406-411
20. The American Diabetes Association's Clinical Practice Guidelines. Available at:. http://diabetes.org/for-health-professionals-and-scientists/cpr.jsp Accessed October 27, 2007
21. Tiemstra J.D., and Khatkhate N. Bell's palsy: diagnosis and management. Am Fam Physician 76 7 (2007) 997-1002
22. Kaiserman I., Kaiserman N., Nakar S., et al. Dry eye in diabetic patients. Am J Ophthalmol 139 3 (2005) 498-503
23. Li H.Y., Pang G.X., and Xu Z.Z. Tear film function of patients with type 2 diabetes. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26 6 (2004) 682-686 [in Chinese]
24. Seifart U., and Strempel I. The dry eye and diabetes mellitus. Ophthalmologie 91 2 (1994) 235-239 [in German]
25. Yoon K.C., Im S.K., and Seo M.S. Changes in tear film and ocular surfaces in diabetes mellitus. Korean J Ophthalmol 18 2 (2004) 168-174
26. Sendecka M., Baryluk A., and Polz-Dacewicz M. Prevalence and risk factors of dry eye syndrome. Przegl Epidemiol 58 1 (2004) 227-233 [in Polish]
27. Mijanovic B., Dana R., Sullivan D.A., et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 143 3 (2007) 409-415
28. Klein B.E., Klein R., and Lee K.E. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126 6 (1998) 782-790
29. Rowe N.G., Mitchell P.G., Cumming R.G., et al. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 7 2 (2000) 103-114
30. Struck H.G., Heider C., and Lautenschlager C. Is diabetes in the elderly patient a risk factor for cataracts?. Ophthalmologe 98 7 (2001) 952-965 [in German]
31. Tkachov S.I., Lautenschlager C., Ehrich D., et al. Changes in the lens epithelium with respect to cataractogenesis: light microscopic and Scheimpflug densitometric analysis of the cataractous and the clear lens of diabetics and non-diabetics. Graefes Arch Clin Exp Ophthalmol 244 5 (2006) 596-602
32. Chew E.Y., Benson W.E., Remaley N.A., et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 117 12 (1999) 1600-1606
33. Krepler K., Biowski R., Schrey S., et al. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 240 9 (2002) 735-738
34. Parness R., Kleinman G., Katz H., et al. Diabetic retinopathy following cataract surgery. Harefuah 144 11 (2005) 763-767 [in Hebrew]
35. Gupta A., and Gupta V. Diabetic maculopathy and cataract surgery. Ophthalmol Clin North Am 14 4 (2001) 625-637
36. Kim S.J., Equi R., and Bressler N.M. Analysis of macula edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 114 5 (2007) 881-889
37. Nakamura M., Kanamori A., and Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica 219 1 (2005) 1-10
38. Vancea P.P., and Abu-Taleb A. Current trends in neovascular glaucoma treatment. Rev Med Chir Soc Med Nat Iasi 109 2 (2005) 264-269 [in Romanian]
39. Kiuchi Y., Sugimoto R., Nakae K., et al. Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica 220 6 (2006) 383-386
40. Konareva-Kostianeva M. Neovascular glaucoma. Folia Med (Plovdiv) 47 2 (2005) 5-11
41. Pasquale L.R., Asefzadeh B., Dunphy R.W., et al., Ocular TeleHealth Team. Detection of glaucoma-like optic discs in a diabetes teleretinal program. Optometry 78 12 (2007) 657-663
42. Voutilainen-Kaunisto R.M., Terasvirta M.E., Uusitupa M.I., et al. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects. Diabetes Care 23 11 (2000) 1672-1678
43. Ng E.W., and Adamis A.P. Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases. Ann N Y Acad Sci 1082 (2006) 151-171
44. Emerson M.V., and Lauer A.K. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. BioDrugs 21 4 (2007) 245-257
45. Davidson J.A., Ciulla T.A., McGill J.B., et al. How the diabetic eye loses vision. Endocrine 31 1 (2007) 107-116
46. Furiani B.A., Meyer C.H., Rodrigues E.B., et al. Emerging pharmacologies for diabetic macular edema. Expert Opin Emerg Drugs 12 4 (2007) 591-603
47. Hatano N., Mizota A., and Tanaka M. Vitreous surgery for diabetic macular edema-its prognosis and correlation between preoperative systemic and ocular conditions and visual outcomes. Ann Ophthalmol (Skokie) 39 3 (2007) 222-227
48. National Eye Institute. Clinical Studies Database: Diabetic Retinopathy Study. Available at:. www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=127 Accessed December 24, 2007
49. National Eye Institute. Clinical Studies Database: Diabetic Retinopathy Study. Available at:. www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=132 Accessed December 24, 2007
50. National Eye Institute. Clinical Studies Database: Diabetic Retinopathy Study. Available at:. www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=105 Accessed December 24, 2007
51. National Eye Institute. Clinical Studies Database: Diabetic Retinopathy Study. Available at:. www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=124 Accessed December 24, 2007
52. Javitt J.C., Zhou Z., and Willke R.J. Association between vision loss and higher medical care costs in Medicare beneficiaries' costs are greater for those with progressive vision loss. Ophthalmology 114 2 (2007) 238-245
53. Rein D.B., Zhang P., Wirth K.E., et al. The economic burden of major adult visual orders in the United States. Arch Ophthalmol 124 (2006) 1754-1760
54. Frick K.D., Gower E.W., Kempen J.H., et al. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol 125 (2007) 544-550
55. Jackson M.L. Vision rehabilitation for Canadians with less that 20/40 acuity: the SmartSight model. Can J Ophthalmol 41 3 (2006) 355-361
56. Klein B.E., Moss S.E., Klein R., et al. Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam eye study. Ophthalmology 110 4 (2003) 644-650
57. Strotmeyer E.S., Cauley J.A., Schwartz A.V., et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 165 14 (2005) 1616-1617
58. Schwartz A.V., Vittinghoff E., Sellmeyer D.E., et al., for the Health ABC Study. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 31 3 (2008) 391-396
59. Ivers R.Q., Cumming R.G., Mitchell P., et al., for the Blue Mountain Eye Study. Diabetes and risk of fracture: the Blue Mountain Study. Diabetes Care 24 7 (2001) 1198-1203
60. Windham B.G., Griswold M.E., Fried L.P., et al. Impaired vision and the ability to take medications. J Am Geriatr Soc 53 7 (2005) 1179-1190
61. Wipf J.E., and Paauw D.S. Ophthalmologic emergencies in the patient with diabetes. Endocrinol Metab Clin North Am 29 4 (2000) 813-829
62. Flynn Jr. H.W., Chew E.Y., Simons B.D., et al. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. EDTRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 99 9 (1992) 1351-1357
63. Roy M.S., Roy A., and Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom Med 69 6 (2007) 537-542
64. Talbot F., and Nouwen A. A review of the relationship between depression and diabetes in adults. Is there a link?. Diabetes Care 23 10 (2000) 1556-1562
65. Freeman E.E., Egleston B.L., West S.K., et al. Visual acuity change and mortality in older adults. Invest Ophthalmol Vis Sci 46 11 (2005) 4040-4045
66. Klein B.E., and Klein R. Ocular problems in older Americans with diabetes. Clin Geriatr Med 6 4 (1990) 827-837
67. Mazza A.D., and Morley J.E. Update on diabetes in the elderly and the application of current therapeutics. J Am Med Dir Assoc 8 8 (2007) 489-492
68. Hass L.B. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities. J Am Med Dir Assoc 8 8 (2007) 502-510
69. Meyers R.M., Broton J.C., Woo-Rippe K.W., et al. Variability in glycosylated hemoglobin values in diabetic patients living in long-term care facilities. J Am Med Dir Assoc 8 8 (2007) 511-514
70. Sinclair S.H. Diabetic retinopathy: the unmet needs for screening and a review of potential solutions. Expert Rev Med Devices 3 3 (2006) 301-313
71. Cundiff D.K., and Nigg C.R. Diet and diabetic retinopathy: insights from the Diabetes Control and Complications Trial (DCCT). MedGenMed 7 1 (2005) 3
72. Hansson-Lundblad C., Agardh E., and Agardh C.D. Retinal examination intervals in diabetic patients on diet treatment only. Acta Ophthalmol Scand 75 3 (1997) 244-248
73. The American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 23 Suppl 2 (2004) S43-S46
74. Koura M.R., Khairy A.E., Abdel-Aal N.M., et al. The role of primary health care in patient education for diabetes control. J Egypt Public Health Assoc 76 3-4 (2001) 241-264
75. Heller T., Maisios M., and Shahar D. Physicians' and nurses' knowledge and attitude towards nutritional therapy in diabetes. Harefuah 146 9 (2007) 670-674 [in Hebrew]
76. Franz M.J. Lifestyle modifications for diabetes management. Endocrinol Metab Clin North Am 26 3 (1997) 499-510
77. Ryan A.S. Insulin resistance with aging: effects of diet and exercise. Sports Med 30 5 (2000) 327-346
78. Tsang T., Orr R., Lam P., et al. Health benefits of Tai Chi for older patients with type 2 diabetes: the "Move It For Diabetes study"-a randomized controlled trial. Clin Interv Aging 2 3 (2007) 429-439
79. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong D.S., Strauber S.F., et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 125 4 (2007) 469-480
80. Lovestam-Adrian M., Agardh C.D., Torffvit O., et al. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation. Acta Ophthalmol Scand 81 3 (2003) 221-225
81. Luttrull J.K., Musch D.C., and Spink C.A. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye (2 February 9, 2007) [Epub ahead of print]
82. Mohamed Q., Gillies M.C., and Wong T.Y. Management of diabetic retinopathy: a systematic review. JAMA 298 8 (2007) 902-916
83. Yam J.C., and Kwok A.K. Update on the treatment of diabetic retinopathy. Hong Kong Med J 13 1 (2007) 46-60
84. Ryan G.J. New pharmacologic approaches to treating diabetic retinopathy. Am J Health Syst Pharm 64 17 Suppl 12 (2007) S15-S21
85. Choi K.S., Chung J.K., and Lin S.H. Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema. Korean J Ophthalmol 21 1 (2007) 11-17
86. Zein W.M., Noureddin B.N., Jurdi F.A., et al. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema. Retina 26 2 (2006) 137-142
87. Arevalo J.F., Fromow-Guerra J., Quiroz-Mercado H., et al., for the Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114 4 (2007) 743-750
88. Haritoglou C., Kook D., Neubauer A., et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26 9 (2006) 999-1005
89. Heisler M., Smith D.M., Hayward R.A., et al. How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services?. Diabetes Care 26 3 (2003) 738-743
90. Heisler M., Piette J.D., Spencer M., et al. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care 28 4 (2005) 816-822
91. Murata G.H., Shah J.H., Hoffman R.M., et al. Diabetes Outcomes in Veterans Study (DOVES). Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 26 6 (2003) 1759-1763
92. Massin P., and Kaloustian E. The elderly diabetic's eyes. Diabetes Metab 33 Suppl 1 (2007) S4-S9
93. Hirai F.E., Moss S.E., Klein B.E., et al. The relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in person s with older-onset diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 31 3 (2008) 493-497
94. West S.K., Munoz B., Istre J., et al. Mixed lens opacities and subsequent mortality. Arch Ophthalmol 118 3 (2000) 393-397